Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gut microbiome and NAFLD: impact and therapeutic potential

27 Nov 2024

Abstract excerpt

Non-Alcoholic Fatty Liver Disease (NAFLD) affects approximately 32.4% of the global population and poses a significant health concern. Emerging evidence underscores the pivotal role of the gut microbiota—including bacteria, viruses, fungi, and parasites—in the development and progression of NAFLD. Dysbiosis among gut bacteria alters key biological pathways that contribute to liver fat accumulation and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clostridium difficile and Clostridium perfringens research
Share to Diet and metabolism studies
Share to Gut microbiota and health

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39664063
DOI: 10.3389/fmicb.2024.1500453

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gut microbiome and NAFLD: impact and therapeutic potentialPMID 39664063Read ↗

Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapiesSemantic proximity Read ↗

Fatty Liver Disease and Gut Microbiota: A Comprehensive UpdateSemantic proximity Read ↗

The gut microbiome and gut-liver axis in NAFLDSemantic proximity Read ↗

Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disordersSemantic proximity Read ↗

The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD)Semantic proximity Read ↗

Characterization of the gut virome in patients with non-alcoholic fatty liver diseaseSemantic proximity Read ↗

NAFLD/MASLD and the Gut–Liver Axis: From Pathogenesis to Treatment OptionsSemantic proximity Read ↗

Gut Microbiota Patterns in Patients with Non-Alcoholic Fatty Liver Disease: A Comprehensive Assessment Using Three Analysis MethodsSemantic proximity Read ↗

Intestinal virome and therapeutic potential of bacteriophages in liver diseaseSemantic proximity Read ↗

The role of microbiota in nonalcoholic fatty liver disease: mechanism of action and treatment strategySemantic proximity Read ↗

Liver tissue microbiota in nonalcoholic liver disease: a change in the paradigm of host-bacterial interactionsSemantic proximity Read ↗

Characterization of the human gut virome in metabolic and autoimmune diseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.